148 related articles for article (PubMed ID: 10767599)
21. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
22. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
23. [Mechanism of oral absorption of panaxnotoginseng saponins].
Han M; Han LM; Wang QS; Bai ZH; Fang XL
Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
[TBL] [Abstract][Full Text] [Related]
24. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Thanou M; Verhoef JC; Marbach P; Junginger HE
J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
[TBL] [Abstract][Full Text] [Related]
25. Prediction of drug intestinal absorption in human using the Ussing chamber system: A comparison of intestinal tissues from animals and humans.
Miyake M; Koga T; Kondo S; Yoda N; Emoto C; Mukai T; Toguchi H
Eur J Pharm Sci; 2017 Jan; 96():373-380. PubMed ID: 27721045
[TBL] [Abstract][Full Text] [Related]
26. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system.
Li H; Jin HE; Shim WS; Shim CK
Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579
[TBL] [Abstract][Full Text] [Related]
27. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism.
Gao F; Zhang Z; Bu H; Huang Y; Gao Z; Shen J; Zhao C; Li Y
J Control Release; 2011 Jan; 149(2):168-74. PubMed ID: 20951749
[TBL] [Abstract][Full Text] [Related]
28. Drug absorption from the isolated perfused rat lung--correlations with drug physicochemical properties and epithelial permeability.
Tronde A; Nordén B; Jeppsson AB; Brunmark P; Nilsson E; Lennernäs H; Bengtsson UH
J Drug Target; 2003 Jan; 11(1):61-74. PubMed ID: 12852442
[TBL] [Abstract][Full Text] [Related]
29. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436
[TBL] [Abstract][Full Text] [Related]
30. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
31. The jejunum is the main site of absorption for anthocyanins in mice.
Matuschek MC; Hendriks WH; McGhie TK; Reynolds GW
J Nutr Biochem; 2006 Jan; 17(1):31-6. PubMed ID: 16098729
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein.
Fong YK; Li CR; Wo SK; Wang S; Zhou L; Zhang L; Lin G; Zuo Z
J Ethnopharmacol; 2012 Jun; 141(2):742-53. PubMed ID: 21906668
[TBL] [Abstract][Full Text] [Related]
33. Discovery of a novel class of orally active, non-peptide angiotensin II antagonists.
De B; Winn M; Zydowsky TM; Kerkman DJ; DeBernardis JF; Lee J; Buckner S; Warner R; Brune M; Hancock A
J Med Chem; 1992 Oct; 35(20):3714-7. PubMed ID: 1433184
[No Abstract] [Full Text] [Related]
34. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
[TBL] [Abstract][Full Text] [Related]
35. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models.
Han M; Fang XL
Acta Pharmacol Sin; 2006 Apr; 27(4):499-505. PubMed ID: 16539852
[TBL] [Abstract][Full Text] [Related]
36. Transport of insulin in modified Valia-Chien chambers and Caco-2 cell monolayers.
Tang C; Yu J; Yin L; Yin C; Pei Y
Drug Dev Ind Pharm; 2007 Apr; 33(4):449-56. PubMed ID: 17523009
[TBL] [Abstract][Full Text] [Related]
37. An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs.
He X; Sugawara M; Kobayashi M; Takekuma Y; Miyazaki K
Int J Pharm; 2003 Sep; 263(1-2):35-44. PubMed ID: 12954178
[TBL] [Abstract][Full Text] [Related]
38. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
[TBL] [Abstract][Full Text] [Related]
39. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model.
Liu Y; Hu M
Drug Metab Dispos; 2002 Apr; 30(4):370-7. PubMed ID: 11901089
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
